Loading...
NPI 1508286071 · Williston, VT · Long Term Care Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Healthdirect Institutional Pharmacy Services, Inc. is a long term care pharmacy provider located in Williston, Vermont. This profile covers 9 Medicare and 10 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Healthdirect Institutional Pharmacy Services, Inc. |
| Address | 600 Blair Park Rd |
| City | Williston |
| State | VT |
| ZIP | 05495 |
| Taxonomy | Long Term Care Pharmacy |
| NPI Enumerated | April 23, 2014 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $503.7K |
| Medicare | $411.2K |
HEALTHDIRECT INSTITUTIONAL PHARMACY SERVICES, INC. bills Medicare largely for vaccine administration: 91322 ($221.9K, 53.9% of this provider's total Medicare revenue), 90662 ($66.6K, 16.2%), and 90480 ($62.1K, 15.1%) together account for the bulk of Medicare activity, and the top 3 Medicare codes by revenue account for 85.2% of this provider's total Medicare revenue. The descriptions of these codes (SARS–CoV–2 vaccine, high‑antigen influenza vaccine, and COVID‑19 vaccine administration) indicate a service mix centered on immunization delivery to Medicare beneficiaries rather than traditional long‑term dispensing or complex pharmacy compounding.
On the Medicaid side, revenue is concentrated in adult incontinence and related disposable products: T4524 ($118.9K, 23.6%), T4527 ($116.5K, 23.1%), and T4528 ($112.2K, 22.3%) are the top Medicaid codes and the top 3 Medicaid codes by revenue account for 69.0% of this provider's total Medicaid revenue. Those code descriptions (adult briefs/underwear and protective underwear) point to a DME/supplies operational emphasis in Medicaid billing, consistent with a long‑term care pharmacy supplying consumable incontinence products to a high‑need population.
The provider’s payer mix shows Medicaid scale modestly exceeds Medicare scale: total Medicaid revenue is $503.7K versus total Medicare revenue of $411.2K, so the organization is not single‑payer and derives a larger share of lifetime revenue from Medicaid. This scale differential, combined with the divergent top codes between payers, suggests dual operational lines—vaccine administration for Medicare and DME/incontinence supply for Medicaid.
National competitive standing on key Medicare vaccine lines is high by rank but described as typical in the source: 91322 ranks #31 of 29357 providers nationally (100th percentile; typical, unremarkable volume) and both 90662 and 90480 rank in the 100th percentile on their respective national lists. In plain terms, the provider appears among the top-ranked national reporters for these vaccine codes while the dataset characterizes the observed volumes as within the expected range for peers rather than as extreme outliers.
In-state competitive positioning for Medicaid DME is concentrated and in several cases dominant: T4524, T4527, T4528, T4535 and T4522 all rank #1 among a small number of Vermont providers for their codes, with T4527, T4528 and T4535 specifically noted as "notably above typical state volume." This pattern signals a local market leadership in supplying adult disposable incontinence products within Vermont.
Several Medicaid lines report claim counts with no paid amounts recorded: J7620 shows 63 claims with $0 avg paid/claim and $0 revenue, and Q0513 shows 385 claims with $0 avg paid/claim and $0 revenue. These zero‑dollar paid records are visible in the billing dataset and may reflect administrative or reimbursement mechanics (e.g., a dispensing fee structure or non‑paid tracking claims) rather than a revenue stream, so analysts should treat those claim counts differently from revenue‑generating codes.
Revenue concentration is high on both payers: the precomputed summaries show top 3 Medicare codes account for 85.2% of Medicare revenue and top 3 Medicaid codes account for 69.0% of Medicaid revenue. This degree of concentration suggests that changes in vaccine demand, immunization programs, or state DME contracting could materially affect overall revenue for this provider.
The provider has an established billing history with an NPI enumeration date of 2014-04-23 (~12 years ago), indicating over a decade of presence in Medicare/Medicaid billing. That tenure, combined with the bifurcated service profile (vaccination services for Medicare and incontinence DME for Medicaid), supports a stable, dual‑line operational footprint rather than a nascent or highly transient billing profile.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
9 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 1,550 | $140 | $221.9K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 930 | $70 | $66.6K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 1,550 | $40 | $62.1K |
| G0008 | Administration of influenza virus vaccine | 970 | $30 | $29K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 90 | $280 | $25.2K |
| 0124A | N/A | 80 | $40 | $3.2K |
| G0009 | Administration of pneumococcal vaccine | 90 | $30 | $2.8K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 20 | $20 | $510 |
| 90688 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It uses split virus technology and is given as a 0.5 mL dose. | 20 | $20 | $360 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 9 CPT/HCPCS codes.
View: State1 / 2
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| T4524 | Adult sized disposable incontinence product, brief/diaper, extra large, each | 2,430 | $50 | $118.9K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 3,530 | $30 | $116.5K |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | 2,490 | $50 | $112.2K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | 3,860 | $20 | $69.5K |
| T4522 | Adult sized disposable incontinence product, brief/diaper, medium, each | 1,640 | $40 | $65.5K |
| T4543 | Adult sized disposable incontinence product, protective brief/diaper, above extra large, each | 380 | $40 | $13.9K |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | 160 | $40 | $6.4K |
| A4554 | Disposable underpads, all sizes | 130 | $10 | $1.2K |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 60 | $0 | $0 |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | 390 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Vermont providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Vermont median
10 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| T4524 | Adult sized disposable incontinence product, brief/diaper, extra large, each | 1 | 10 | 370 | $60 | $55.9K |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | 1 | 10 | 310 | $60 | $39.1K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 1 | 10 | 320 | $40 | $35K |
| T4522 | Adult sized disposable incontinence product, brief/diaper, medium, each | 1 | 10 | 180 | $50 | $27.1K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | 1 | 10 | 350 | $30 | $23.9K |
| A4554 | Disposable underpads, all sizes | 3 | 10 | 380 | $30 | $18.2K |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | 5 | 10 | 130 | $70 | $15.8K |
| T4543 | Adult sized disposable incontinence product, protective brief/diaper, above extra large, each | 1 | 10 | 380 | $40 | $13.9K |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | 1 | 10 | 40 | $1 | $350 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 3 | 10 | 60 | $1 | $10 |
Other providers in the same ZIP code as Healthdirect Institutional Pharmacy Services, Inc., ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Primary Care Health Partners - Vermont LLP | VT | Family Medicine Physician | $0 | $2.8M |
| Brian Ashley, Ma, Plc | VT | Psychologist | $0 | $1M |
| Evergreen Family Health Partners | VT | Family Medicine Physician | $0 | $626.1K |
| Town Of Williston | VT | Ambulance | $160.7K | $234.6K |
| Lisa Angstman | VT | Clinical Psychologist | $116.1K | $261.4K |
| Benjamin Physical Medicine, Plc | VT | Medical Specialty Clinic/Center | $0 | $307.8K |
| Thomas Chittenden Health Center, Plc | VT | Family Medicine Physician | $0 | $288.9K |
| Beth Morelli | VT | Mental Health Counselor | $0 | $288.7K |
| Sawyer Lecompte | VT | Mental Health Counselor | $0 | $284.7K |
| Kathleen Kelley | VT | Mental Health Counselor | $0 | $242.3K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.